RAC3 and hepatocellular carcinoma: Moreover, we demonstrated that RAC3 interacting with SOX6 facilitated the malignant phenotypes of HCC cells via NNMT‐mediated activation of cAMP/MAPK/Rap1 signaling and inhibition of RAC3 by small molecular inhibitor EHop‐016 significantly suppressed HCC growth.